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Key Points 
Question: How does the development of infants with multiplex and single-incidence family risk 
for autism spectrum disorder (ASD) differ? 
 
Findings: In this prospective, longitudinal study that included 445 children with multiplex 
(n=80) or single-incidence (n=355) family risk, 68% of children from multiplex families vs. 43% 
of those from single-incidence families had ASD or atypical development at outcome. Non-ASD 
children did not differ in ASD symptoms based on family risk status, but multiplex status was 
associated with lower cognitive abilities by age 3.  
 
Meaning: Infants with a multiplex family history of ASD should be monitored early and often 





Importance: Autism spectrum disorder (ASD) is a neurodevelopmental disorder associated with 
different genetic etiologies. Prospective examination of familial-risk infants informs 
understanding of developmental trajectories preceding ASD diagnosis, potentially improving 
early detection.  
Objective: Compare outcomes and trajectories associated with varying familial risk for ASD 
across first 3 years of life. 
Design and Setting: Longitudinal, prospective observational study. Data from 11 sites in Baby 
Siblings Research Consortium (BSRC) database included. Data collected between 2003-2015. 
Infants followed for 3 years. Analyses conducted in 2018.  
Participants: Of initial 1,008 infants from BSRC database, 573 removed due to missing 
necessary data, diagnostic discrepancies, or only one older sibling. 435 younger siblings of 
children with ASD included; 355 from single-incidence families (1 sibling with ASD and 1+ 
sibling without ASD) and 80 from multiplex families (2+ siblings with ASD). No group 
differences in major demographics.  
Exposure: Number of ASD-siblings. 
Main Outcomes and Measures: Outcomes included ASD symptoms, cognitive abilities, and 
adaptive skills. Diagnosis (ASD/no-ASD) given at 36-month outcome. No-ASD group classified 
as atypical (developmental delays and/or social-communication concerns) or typical for some 
analyses. Generalized linear mixed models examined developmental trajectories by ASD 
outcome and familial-risk group.  
Results: In the 435 analyzed participants (age range at outcome: 32-43 months; 57% male), 
children from multiplex families were more likely than those from single-incidence families to 
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be classified as ASD (36% vs. 16%, p<.001) and less likely as typical (33% vs. 57%, p<.001), 
with similar rates of atypical classifications (31% vs. 27%, p=.49). No differences in ASD 
symptoms between multiplex and single-incidence groups, after controlling for ASD outcome 
(p=.18). During infancy, differences in cognitive and adaptive abilities observed based upon 
ASD outcome in single-incidence group only (ps<.001-.04). At 36 months, multiplex/no-ASD 
group had lower cognitive abilities than single-incidence/no-ASD group (p=.02), and multiplex 
had lower adaptive abilities than single-incidence, after controlling for ASD outcome (p=.02).  
Conclusions and Relevance: Infants with a multiplex family history of ASD should be 
monitored early and often and referred for early intervention at the first sign of concern. Direct 
examination of genetic contributions to neurodevelopmental phenotypes in infants with familial 
risk for ASD is needed.  
 




Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by 
deficits in social communication and the presence of restricted and repetitive patterns of 
behavior1. Recent estimates indicate an ASD prevalence of 1 in 59 children and a typical age of 
diagnosis of 4 years old2. Converging evidence suggests that there are multiple genetic pathways 
to ASD3,4. One genetic risk group that has been studied widely includes infants with at least one 
older sibling with ASD (familial-risk). Prospective studies of these infants have helped to 
characterize the early emergence of developmental differences associated with later ASD 
diagnosis, with the identification of these early signs ultimately improving early screening and 
intervention efforts5.  
To overcome the challenge of small sample sizes and to facilitate scientific collaboration 
in prospective studies of familial-risk infants, the Baby Siblings Research Consortium (BSRC) 
was formed. BSRC researchers have combined data from common measures across many sites to 
answer clinically-relevant questions about early manifestations of ASD. BSRC research indicates 
that nearly 20% of familial-risk infants will meet criteria for ASD at age 36,7 and another 
approximately 20% will show other developmental atypicalities (e.g., developmental delays, 
subclinical ASD symptoms)8,9. One key question arising from these prospective studies is 
whether neurodevelopmental outcomes vary based on genetic risk, with variability in risk 
defined by the number of siblings with ASD. Multiplex ASD (2+ ASD-siblings) is more 
commonly associated with the additive risk of common genetic variants and inherited copy 
number variants (CNVs)10,11, while single-incidence ASD (one ASD-sibling) is more often 
caused by rare de novo CNVs and mutations11. 
Prior BSRC studies have shown that 60% of male and 30% of female children with 
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multiplex family risk have ASD compared to nearly 30% of male and 10% of female children 
with single-incidence family risk6. Profile analyses of these infants indicated that multiplex 
status is associated with decreased cognitive scores, but no difference in ASD symptoms6. 
Family-based studies have demonstrated that the non-ASD siblings of children with ASD from 
multiplex families have a higher level of subclinical ASD symptoms12,13, while the degree to 
which cognitive abilities differ among non-ASD siblings based on familial-risk status is less 
clear14. No studies have analyzed differences in developmental trajectories in infancy based on 
multiplex versus single-incidence status. 
Using the BSRC database, we comprehensively examined categorical distinctions and 
developmental trajectories in social-communication, cognitive, and adaptive skills associated 
with different levels of familial risk across the first 3 years of life. We sought to answer three 
primary questions: (1) How do rates of typical, atypical (non-ASD), and ASD outcomes differ 
between infants from multiplex and single-incidence families? (2) When and how do 
developmental trajectories of ASD symptoms, cognitive ability, and adaptive skills across the 
first 3 years diverge based on familial-risk status and ASD diagnostic outcome? (3) For children 
without ASD, how do the phenotypic profiles differ at 3-year outcome based on familial-risk 
status? We expected greater impairment in infants from multiplex families versus single-
incidence families, with higher rates of ASD overall, as well as lower developmental and 
adaptive abilities, and higher subclinical ASD symptoms in non-ASD children. Results of these 
analyses can help guide clinicians in earlier and more informed developmental screening and 




 Out of an initial sample of 1,008 infants from the BSRC database, 435 younger siblings 
of children with ASD who were enrolled in longitudinal studies across 11 BSRC sites met 
inclusion criteria (partially overlapping with previous BSRC samples6,7). Children in the 
multiplex group had 2+ older siblings with ASD. Unlike previous BSRC studies6,7, children in 
the single-incidence group had a single older sibling with ASD and 1+ older sibling(s) without 
ASD. Confirmation of older sibling diagnoses and time points varied by study site.  
Participants were removed due to missing required outcome (n=110) or older sibling data 
(n=8), discrepancies between ADOS score and diagnosis (n=15), and having only one older 
sibling (n=404) or multiple siblings from the same family (n=36). When multiple children from a 
family participated, only the youngest child was included to maximize information on older 
siblings.  
Groups were comparable with regard to demographic characteristics (Table 1). The 
multiplex group had larger families than the single-incidence group. IRB approval and written 
informed consent for all participants was obtained within each study site.  
Measures 
 ASD symptoms were measured at 18, 24, and 36 months of age using the Autism 
Diagnostic Observation Schedule (ADOS)15, an observational measure of social-communication 
and repetitive behaviors. The ADOS yields a Calibrated Severity Score (CSS) ranging from 1-
1016,17. The CSS-Overall score was used in longitudinal analyses. The Social Affect (SA) and 
Restricted, Repetitive Behavior (RRB) subscale scores were examined in outcome analyses. The 
Autism Diagnostic Interview-Revised (ADI-R)18, a parent interview, was collected at 36 months 
in a subset of infants and used as a secondary indicator of ASD symptoms in outcome analyses. 
Cognitive abilities were measured at 6, 9, 12, 15, 18, 24, and 36 months, using the 
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Mullen Scales of Early Learning (MSEL)19. The MSEL examines Visual Reception, Fine Motor, 
Receptive Language, and Expressive Language, which yield t-scores (M=50, SD=10). An Early 
Learning Composite (ELC) is also calculated, yielding a standard score (M=100, SD=15) 
representing a child’s overall cognitive ability relative to peers. The ELC was used in 
longitudinal analyses. Subscale scores were analyzed in outcome analyses.  
 Adaptive skills were assessed at 6, 9, 12, 15, 18, 24, and 36 months in a subset of infants 
using the Vineland Adaptive Behavior Scales-Second Edition (Vineland-II)20, a parent-report 
measure. The Vineland-II assesses Communication, Daily Living Skills, Socialization, and 
Motor Skills, which produce standard scores. The Adaptive Behavior Composite (ABC) is 
computed from the first three domains, yielding a standard score representing an individual’s 
overall adaptive ability relative to peers. The ABC was utilized in longitudinal analyses. 
Subscale scores were examined in outcome analyses. 
Clinical outcomes were determined following the 36-month assessment. Children were 
classified as ASD (n=86; vs. no-ASD, n=349) if they had a clinical best estimate diagnosis of 
ASD by expert clinicians and an ADOS score at or above the clinical threshold (CSS  4)7. For 
categorical analyses only, the no-ASD group was split into a typical (n=227; MSEL ELC  85 
and ADOS CSS < 3) and atypical group (n=122; MSEL ELC < 85 and/or ADOS CSS  3)8,21. 
Within the atypical group, 25.9% fell into this group due to lower cognitive scores, 64.7% due to 
elevated ADOS scores, and 9.5% due to both factors (Table 1). 
Statistical Analyses 
Longitudinal trajectories of primary outcome variables (ADOS CSS-Overall, MSEL 
ELC, Vineland-II ABC) were modeled using generalized linear mixed models (GLMM) with 
main effects of ASD outcome (ASD vs. no-ASD), familial-risk status (multiplex vs. single-
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incidence), and time, along with their two-way and three-way interactions. Subject-specific and 
site-specific random intercepts were included to model dependency due to repeated measures 
within subjects and sites. MSEL and Vineland-II scores were modeled employing an identity-
link, while ADOS scores were modeled using a negative binomial GLMM with a log-link. Time 
was modeled as a class variable for ADOS (at 18, 24, and 36 months), with a broken-line model 
allowing for a slope change at 18 months for MSEL and linearly for Vineland-II (where a slope 
change at 18 months was non-significant). Two-way and three-way interactions between ASD 
outcome, familial-risk status, and time were found significant in models for Vineland-II and 
MSEL; however, the final GLMM for ADOS only contained the significant two-way interaction 
between ASD outcome and time.  
According to the interactions found significant and our hypotheses, we conducted 6 
contrasts for MSEL and Vineland-II data at pre-selected time points to evaluate group mean 
differences between: (1) ASD and no-ASD single-incidence, (2) ASD and no-ASD multiplex, (3) 
no-ASD multiplex and single-incidence, (4) ASD multiplex and single-incidence, (5) (ASD 
multiplex – no-ASD multiplex) and (ASD single-incidence – no-ASD single-incidence), (6) 
multiplex and single-incidence. Contrasts were conducted at 6, 12, 24, and 36 months for MSEL 
and 12, 24 and 36 months for Vineland-II (time points with most observations). For the final 
ADOS model, we conducted contrasts between: 1) ASD and no-ASD groups at 18, 24, and 36 
months, and 2) multiplex and single-incidence groups (ages collapsed). We used false discovery 
rate (FDR)22 at .05 to adjust for multiple comparisons (46 contrasts).  
GLMMs account for correlations between repeated measures within subjects, allowing 
for fixed and time-varying covariates and automatically handling missing data, thereby 
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producing unbiased estimates as long as observations are missing at random. Accordingly, all 
available observations from each subject were utilized in modeling via GLMM.  
Results 
36-month outcome classifications based on familial-risk status 
 Outcome classifications significantly differed based on familial-risk status, 2(2, 
N=435)=21.10, p<.001. The multiplex group was more likely than the single-incidence group to 
be classified as ASD (36.3% vs. 16.1%), p<.001, less likely to be classified as typical (32.5% vs. 
56.6%), p<.001, and had similar levels of atypical classifications (31.3% vs. 27.3%), p=.49.  
Developmental trajectories based on familial-risk status and ASD outcome 
Results from the final GLMMs are summarized below. See Figure 1 for depictions of 
modeled developmental trajectories, Table 2 for detailed sample size information, and Table 3 
for contrast results (eFigure1 presents raw trajectories).  
 ASD symptoms. ASD symptoms differed between the ASD and no-ASD groups, 
regardless of familial-risk status, at 18, 24, and 36 months. Children with ASD outcomes showed 
higher levels of ASD symptoms than children without ASD beginning at 18 months. No 
differences in ASD symptoms were found between the multiplex and single-incidence groups, 
after controlling for ASD outcome. 
 Cognitive abilities. Within the single-incidence group, children with ASD outcomes had 
lower cognitive abilities than no-ASD children at 6, 12, 24, and 36 months. In the multiplex 
group, the ASD and no-ASD groups did not differ at 6 or 12 months; instead, differences 
emerged at 24 months, with the ASD group demonstrating lower cognitive abilities than the no-
ASD group at 24 and 36 months. Within the no-ASD group, the multiplex group had lower 
cognitive abilities than the single-incidence group at 36 months; cognitive abilities did not differ 
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based on familial-risk status among no-ASD children at earlier ages. In the ASD group, cognitive 
abilities did not differ between multiplex and single-incidence groups. There was, however, an 
overall difference in cognitive abilities between multiplex and single-incidence groups (ASD + 
no-ASD contrast) at 36 months. Finally, the difference in cognitive abilities among ASD and no-
ASD children differed between the multiplex and single-incidence groups (ASD – no-ASD 
contrast) at 6 months. As depicted in Figure 1b, children with ASD outcomes had lower 
cognitive abilities than those without ASD within the single-incidence group at 6 months, while 
multiplex children had similar abilities at this age regardless of ASD outcome. 
 Adaptive skills. Within the single-incidence group, children with ASD outcomes had 
lower adaptive abilities than no-ASD children at 12, 24, and 36 months. Within the multiplex 
group, children with and without ASD outcomes showed similar levels of adaptive abilities at 12 
months, which then diverged at 24 and 36 months. The multiplex and single-incidence groups 
did not, however, differ significantly within the ASD and no-ASD groups. Likewise, overall 
familial-risk group differences were mostly non-significant. At 36 months, there were overall 
differences based on familial-risk status; the multiplex group had lower adaptive abilities than 
the single-incidence group. 
36-month developmental profiles based on familial-risk status in no-ASD children  
See Table 4 for descriptive information and statistical results (depicted in eFigure2). 
Results are reported with and without correction for multiple comparisons (13 contrasts). No-
ASD children from multiplex and single-incidence groups showed similar levels of social-
communication skills and RRBs on the ADOS and ADI-R, and communication, socialization, 
daily living, and motor skills on the Vineland-II. On the MSEL, however, the multiplex group 
had lower visual reception and receptive language scores than the single-incidence group; the 
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difference in receptive language survived FDR correction. 
Discussion 
 This longitudinal investigation indicated areas of similarity and difference associated 
with varying levels of familial risk for ASD.  
Rates of ASD 
Children from multiplex families were more than twice as likely to have ASD outcomes 
as those from single-incidence families. While 57% of the children with only one older sibling 
with ASD were typically developing at age 3, only 33% of the children with multiple older 
siblings with ASD were typically developing at outcome. This finding highlights the first and 
most important clinical finding of this study: infants with a strong family history of ASD need to 
be monitored early and often, and should be referred for early intervention services at the first 
sign of concern.  
Developmental trajectories 
 Longitudinal analyses suggest that group differences over time in ASD symptoms, 
cognitive abilities, and adaptive skills were mainly attributable to ASD outcome rather than 
familial-risk status. This was particularly true for ASD symptoms, which differed only based 
upon ASD outcome beginning at 18 months. Within the single-incidence group, children with 
ASD outcomes consistently demonstrated lower cognitive abilities than children without ASD 
beginning at 6 months and adaptive abilities beginning at 12 months (earliest ages contrasted). 
Conversely, multiplex infants showed similar levels of cognitive and adaptive abilities at earlier 
ages, regardless of ASD outcome, and did not diverge until the second year of life. Multiplex 
children with ASD outcomes demonstrated a sharp decline in standard scores on measures of 
early cognitive and adaptive skills in the second and third years of life, reflecting slower growth 
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in these developmental abilities. Neuroimaging studies of familial-risk infants have identified 
altered trajectories of brain development in the first year, particularly in cortical surface area and 
neural connectivity23,24. These studies have not distinguished infants based on multiplex versus 
single-incidence status, but they support the hypothesis that genetic risk factors lay a foundation 
for early changes in brain structure and function, which may then cumulatively disturb learning 
and adaptive behaviors leading to difficulties making expected developmental gains. These 
neurobiological changes may truly precede behavior; alternatively, our standardized behavioral 
measures may lack sensitivity to discern subtle changes in development in the first year. 
Clinically, these results suggest that it may be more challenging to distinguish infants with ASD 
versus no-ASD behaviorally in the context of multiplex status during infancy and early 
toddlerhood. Further research longitudinally examining biomarkers of risk early in life is needed 
to determine which infants are most likely to need pre-emptive intervention in this 
population25,26. 
Profile analyses 
 We also detected subtle differences and remarkable similarities between multiplex and 
single-incidence children without ASD at outcome. Non-ASD children did not differ based on 
familial-risk status in their observed or parent-reported levels of ASD symptoms at age 3. This 
was somewhat surprising given previous research suggesting subclinical ASD symptoms in 
family members of individuals with ASD (i.e., broader autism phenotype), particularly families 
with multiple affected individuals13,27. It is possible that our ASD symptom measures, which 
were designed as clinical diagnostic tools, were not sensitive enough to detect subtle differences 
in social-communication and repetitive behavior.  
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We did, however, detect differences in cognitive abilities at age 3. This finding was 
primarily explained by differences in receptive language, and, to a lesser degree, nonverbal 
cognitive skills, with no differences in broadly-measured expressive language found between the 
non-ASD multiplex and single-incidence groups. These results are largely consistent with 
previous research finding deficits in verbal IQ in the unaffected siblings of multiplex but not 
single-incidence families14. The likely risk factors for having multiple children with ASD, such 
as shared genetic variation, vulnerability to genetic mutations, or complex gene-environment 
interactions (e.g., in utero environment) may impact brain development in a more distributed, 
global way, which then impacts overall development, rather than networks that are more specific 
to ASD. These findings speak to the need for large, collaborative efforts to examine brain 
development, genetics, and gene-environment interactions in at-risk infants to understand the 
neurobiological mechanisms underlying these differences in developmental trajectories and 
behavior.  
Strengths and limitations 
Our study uniquely leveraged a rich dataset collected from multiple expert sites to 
prospectively examine differences associated with multiplex status and diagnostic outcome in a 
large cohort of infants with elevated familial risk for ASD. Although the sample size was quite 
large for a study of this kind, the prospective nature led to uneven and occasionally small groups 
disallowing investigation in some areas of interest (e.g., sex) and firm conclusions in others. For 
instance, the multiplex group was smaller, so comparisons within this group were less powered 
than those within the single-incidence group. Given the longitudinal, multi-site design, there was 
also some inconsistency among study sites in the ages at which different measures were 
collected, how older sibling diagnoses were confirmed, as well as missing data. Statistical 
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models that account for missing data and site differences helped to attenuate possible negative 
effects. The use of already-collected data across multiple sites also required us to choose 
common broad-based measures that, while highly clinically relevant and well-validated, may not 
have been sensitive enough to detect more subtle differences between the non-ASD children. 
Additionally, as is the case across the ASD-sibling literature28, many of the children in the 
sample had relatively high cognitive scores and came from predominantly Caucasian and highly-
educated families, so these results may not represent the larger population of children with ASD. 
The most substantial limitation is the lack of genomic data in these infants, which would inform 
our hypotheses about genetic factors contributing to developmental differences.   
Conclusions 
  Children from multiplex families are more than twice as likely to meet criteria for ASD at 
age 3 than children from single-incidence families. Prospectively, single-incidence infants begin 
to show developmental differences based on later ASD diagnosis by 6 months of age, while 
multiplex infants with and without ASD outcomes do not differ until the second year of life. 
Among unaffected children, multiplex risk is associated with lower cognitive abilities, but 
similar levels of ASD symptoms. Results support the need for direct examination of genetic 
contributions to neurodevelopmental phenotypes in infants with multiplex and single-incidence 
family risk for ASD. Given their very high rates of ASD and other neurodevelopmental 
challenges, infants with a strong family history of ASD should be monitored early and often and 
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Sex (male) n (%) 200 (56.3) 46 (57.5) .85 
Race/ethnicity (non-Caucasian) n (%) 86 (24.3) 14 (17.5) .36 
Maternal education (college or higher) n (%) 233 (65.7) 53 (66.7) .92 
Maternal age at birth (years) M (SD) 34.86 (4.82) 34.57 (4.87) .69 
Paternal age at birth (years) M (SD) 37.37 (5.81) 37.35 (6.26) .98 
Number of children in family M (SD) 3.46 (.79) 3.83 (1.35) .02 
Number of ASD siblings M (SD) 1.00 (0) 2.13 (.44) <.001 
Age first seen (months) M (SD) 6.90 (4.24) 7.23 (4.14) .53 
Age at outcome (months) M (SD) 37.28 (1.63) 37.48 (1.92) .34 






ASD symptoms (ADOS) M (SD) 
Overall 1.30 (.46) 3.52 (1.77) 6.85 (1.78) 
Social Affect  1.64 (.77) 3.85 (2.08) 6.67 (1.83) 
RRB 3.10 (2.37) 5.07 (2.45) 7.58 (1.91) 
Cognitive abilities (MSEL) M (SD) 
Early Learning Composite 110.49 (14.37) 96.90 (19.84) 81.06 (24.42) 
Visual Reception 61.25 (10.31) 53.14 (15.14) 42.54 (18.84) 
Fine Motor 52.90 (12.65) 44.73 (12.81) 36.12 (12.75) 
Receptive Language 52.77 (8.84) 46.61 (9.86) 38.52 (14.31) 
Expressive Language 54.14 (7.82) 47.84 (10.94) 39.81 (13.56) 
Adaptive skills (Vineland-II) M (SD) 
Adaptive Behavior Composite 94.95 (12.11) 90.37 (13.84) 79.14 (13.73) 
Communication  100.90 (13.18) 96.12 (14.16) 85.22 (16.32) 
Daily Living Skills 94.95 (11.41) 89.95 (15.90) 80.55 (14.04) 
Socialization 97.66 (12.68) 92.97 (12.85) 79.59 (13.21) 
Motor Skills 94.88 (12.06) 92.00 (12.71) 84.83 (12.78) 
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Note. Group differences between categorical variables assessed using chi-square tests, and 
continuous variables using t-tests. ADOS calibrated severity score (1-10), Vineland-II composite 
and domain standard scores (M=100, SD=15), MSEL composite standard score (M=100, SD=15) 
and subscale t-scores (M=50, SD=10) presented. *Groups differed on all outcome variables. 
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Table 2. Number of participants with data by age, measure, and group status 








Total in sample 298 57 51 29 
ADOS     
18 214 39 36 23 
24 260 54 44 27 
36 298 57 51 29 
MSEL     
6 175 29 28 13 
9 48 11 14 5 
12 249 38 41 23 
15 57 16 11 7 
18 113 19 18 15 
24 266 49 48 27 
36 294 56 49 27 
Vineland-II     
6 38 9 5 2 
9 38 9 4 3 
12 148 26 21 14 
15 42 13 7 3 
18 177 28 29 17 
24 187 37 28 18 
36 210 39 30 17 
ADI-R     
36 136 37 28 15 
Note. GLMM models used all available data to inform estimates.  
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Table 3. GLMM contrast results 
Group Contrast Age (mos) Estimate (SE) df t p f 
Observed ASD symptoms (ADOS) 
- ASD vs. No-ASD 18 .73 (.08) 693 8.95 <.001 .34 
- ASD vs. No-ASD 24 .78 (.07) 693 10.95 <.001 .42 
- ASD vs. No-ASD 36 1.16 (.07) 693 17.94 <.001 .68 
- Multiplex vs. Single - .09 (.06) 693 1.67 .18 .06 
Group Contrast Age (mos) Estimate (SE) df t p f 
Cognitive abilities (MSEL) 
Single-incidence ASD vs. No-ASD 6 -6.52 (2.67) 1304 -2.45 .04 .07 
Single-incidence ASD vs. No-ASD 12 -10.15 (2.02) 1304 -5.04 <.001 .14 
Single-incidence ASD vs. No-ASD 24 -17.53 (2.04) 1304 -8.58 <.001 .24 
Single-incidence ASD vs. No-ASD 36 -25.01 (2.35) 1304 -10.65 <.001 .30 
Multiplex ASD vs. No-ASD 6 5.67 (4.30) 1304 1.32 .29 .04 
Multiplex ASD vs. No-ASD 12 -5.89 (3.17) 1304 -1.86 .13 .05 
Multiplex ASD vs. No-ASD 24 -18.84 (3.18) 1304 -5.92 <.001 .16 
Multiplex ASD vs. No-ASD 36 -21.61 (3.81) 1304 -5.68 <.001 .16 
No-ASD Multiplex vs. Single 6 -2.48 (2.67) 1304 -.93 .44 .03 
No-ASD Multiplex vs. Single 12 -.65 (2.05) 1304 -.32 .79 .01 
No-ASD Multiplex vs. Single 24 -1.56 (2.11) 1304 -.74 .51 .02 
No-ASD Multiplex vs. Single 36 -7.05 (2.47) 1304 -2.85 .02 .08 
ASD Multiplex vs. Single 6 9.71 (4.31) 1304 2.26 .05 .06 
ASD Multiplex vs. Single 12 3.61 (3.16) 1304 1.14 .36 .03 
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ASD Multiplex vs. Single 24 -2.88 (3.15) 1304 -.91 .44 .03 
ASD Multiplex vs. Single 36 -3.65 (3.74) 1304 -.98 .43 .03 
ASD – No-ASD Multiplex vs. Single 6 12.20 (5.06) 1304 2.41 .04 .07 
ASD – No-ASD Multiplex vs. Single 12 4.26 (3.76) 1304 1.13 .36 .03 
ASD – No-ASD Multiplex vs. Single 24 -1.32 (3.79) 1304 -.35 .78 .01 
ASD – No-ASD Multiplex vs. Single 36 3.40 (4.48) 1304 .76 .50 .02 
ASD + No-ASD Multiplex vs. Single 6 3.61 (2.54) 1304 1.43 .26 .04 
ASD + No-ASD Multiplex vs. Single 12 1.48 (1.89) 1304 .79 .50 .02 
ASD + No-ASD Multiplex vs. Single 24 -2.22 (1.90) 1304 -1.17 .36 .03 
ASD + No-ASD Multiplex vs. Single 36 -5.35 (2.25) 1304 -2.38 <.05 .07 
Group Contrast Age (mos) Estimate (SE) df t p f 
Adaptive skills (Vineland-II) 
Single-incidence ASD vs. No-ASD 12 -7.59 (1.76) 843 -4.32 <.001 .15 
Single-incidence ASD vs. No-ASD 24 -9.82 (1.52) 843 -6.43 <.001 .22 
Single-incidence ASD vs. No-ASD 36 -12.05 (1.94) 843 -6.21 <.001 .22 
Multiplex ASD vs. No-ASD 12 -2.62 (3.01) 843 -0.87 .45 .03 
Multiplex ASD vs. No-ASD 24 -9.38 (2.50) 843 -3.75 .001 .13 
Multiplex ASD vs. No-ASD 36 -16.14 (3.32) 843 -4.87 <.001 .17 
No-ASD Multiplex vs. Single 12 -4.14 (1.93) 843 -2.14 .07 .07 
No-ASD Multiplex vs. Single 24 -3.67 (1.61) 843 -2.28 .05 .08 
No-ASD Multiplex vs. Single 36 -3.20 (2.12) 843 -1.51 .23 .05 
ASD Multiplex vs. Single 12 .82 (2.90) 843 0.28 .79 .01 
ASD Multiplex vs. Single 24 -3.23 (2.45) 843 -1.32 .29 .05 
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ASD Multiplex vs. Single 36 -7.29 (3.20) 843 -2.28 .05 .08 
ASD – No-ASD Multiplex vs. Single 12 4.96 (3.49) 843 1.42 .26 .05 
ASD – No-ASD Multiplex vs. Single 24 .44 (2.93) 843 .15 .88 .01 
ASD – No-ASD Multiplex vs. Single 36 -4.09 (3.84) 843 -1.07 .39 .04 
ASD + No-ASD Multiplex vs. Single 12 -1.65 (1.74) 843 -.95 .46 .03 
ASD + No-ASD Multiplex vs. Single 24 -2.56 (1.51) 843 -1.69 .18 .06 
ASD + No-ASD Multiplex vs. Single 36 -5.25 (1.92) 843 -2.73 .02 .08 
Note. Reported p-values are FDR corrected.  
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Table 4. Detailed comparison of 36-month outcome data across familial-risk groups in no-ASD children 
Variable M (SD) Single-incidence Multiplex praw pFDR d 
Cognitive abilities (MSEL) 
Visual Reception 59.14 (12.26) 54.70 (14.85) .05 .22 .33 
Fine Motor 50.66 (13.03) 46.96 (14.32) .07 .22 .27 
Receptive Language 51.80 (9.91) 47.61 (8.80) .003 .04 .45 
Expressive Language 52.28 (9.38) 50.39 (9.89) .20 .29 .20 
Observed ASD symptoms (ADOS) 
Social Affect 2.38 (1.74) 2.63 (1.68) .35 .41 .15 
RRB 3.68 (2.58) 4.41 (2.48) .06 .22 .29 
Reported ASD symptoms (ADI-R) 
Social Interaction 2.66 (2.30) 3.82 (3.84) .13 .29 .37 
Communication 2.39 (2.50) 3.29 (3.47) .20 .29 .30 
RRB .73 (1.39) 1.29 (1.86) .14 .29 .34 
Adaptive skills (Vineland-II) 
Communication 99.57 (13.61) 96.03 (14.33) .17 .29 .25 
Daily Living Skills 93.47 (13.43) 90.24 (13.71) .23 .30 .24 
Socialization 96.17 (12.03) 93.85 (17.62) .46 .50 .15 
Motor Skills 93.90 (11.62) 93.07 (16.81) .80 .80 .06 
Note. Both uncorrected (praw) and FDR-corrected (pFDR) p-values reported.  
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Figure 1. Developmental trajectories of (a) ASD symptoms, (b) cognitive abilities, and (c) adaptive skills  
 
 
Figure 1 caption. Depiction of results from Generalized Linear Mixed Models. ADOS measured ASD symptoms, MSEL measured 
cognitive abilities, and Vineland-II measured adaptive skills. ADOS=Autism Diagnostic Observation Schedule. CSS=Calibrated 
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